Karyopharm to participate at the 2024 rbc capital markets global healthcare conference

Newton, mass. , may 8, 2024 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate at the 2024 rbc capital markets global healthcare conference in a fireside chat on wednesday, may 15 at 9:30 a.m.

KPTI Ratings Summary

KPTI Quant Ranking